<DOC>
	<DOCNO>NCT00726648</DOCNO>
	<brief_summary>Comparison effect different CDP323 dos give period four week blood biomarkers subject relapse form multiple sclerosis .</brief_summary>
	<brief_title>CDP323 Biomarker Study</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Female male subject age 1865 year Relapsing form MS least one clinical relapse 24 month screen ; Screening EDSS score 06.5 ; Must fully immunocompetent Female subject childbearing potential must agree practice contraception method Any condition could interfere contrastenhanced MRI ; Any clinically significant disease state finding MS ; Any clinically significant deviation predefined range laboratory test ; Concomitant treatment MS disease modify drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>CDP323</keyword>
	<keyword>Relapsing multiple sclerosis</keyword>
	<keyword>Blood biomarkers</keyword>
</DOC>